SOLB Solvay SA

Mark your calendar for Solvay 2021 financial events

Mark your calendar for Solvay 2021 financial events

Mark your calendar for Solvay 2021 financial events

Brussels, December 15, 2020, 08:30 CET - Solvay today publishes its 2021 financial calendar and invites the financial community to mark their calendar accordingly.

EventDate
Full year 2020 earningsFebruary 24, 2021
First quarter 2021 earningsMay 5, 2021
Ordinary General Shareholders’ MeetingMay 11, 2021
First half year 2021 earningsJuly 29, 2021
First nine months 2021 earningsOctober 28, 2021

Quiet period dates will be provided prior to each earnings’ season.

We invite you to to receive events notifications.

 

Recent webcasts and presentations

  •  (November 5)
  • (October 2)

 

More information can be found on

 

Attachment



EN
15/12/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Solvay SA

Stijn Demeester
  • Stijn Demeester

Solvay/Expectations reset, yield remains attractive/BUY

We update our model and lower our Und. EBITDA estimates by c.12% to reflect Solvay's 2Q25 results and lowered guidance. We reduce our target price to €30 per share from €33.50 yet keep our BUY on the back of Solvay's attractive dividend yield.

Solvay SA: 1 director

A director at Solvay SA bought 1,083 shares at 27.740EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Wim Hoste
  • Wim Hoste

Solvay Feedback conference call

Below are the key highlights from the conference call. Solvay's 1Q25 uEBITDA dropped 15% to € 230m, in line with the recent profit warning. Solvay reiterated the (recently cut) FY25 underlying EBITDA guidance of € 880-930m (c. -12% at midpoint vs the previous € 1.0-1.05bn range), citing continued soft demand in a context of tariff and geopolitical uncertainty. Solvay had already stated to maintain FCF guidance of c. € 300m (on the back of more prudent capex spending) which however still means th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch